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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A191Among the 493 genes, we observed the reported AI events in OA sus-
ceptibility genes (e.g. ALDH1A2, DIO2, GDF5, ﬁgure 1), as well as a
substantial number of novel AI events in cartilage expressed genes (e.g.
PTGES3P1, CHST6, ITGA10, CD55, ﬁgure 1). Next, to gain disease relevant
insight in the direction of the observed AI, we addressed differential
gene expression between preserved and paired lesioned cartilage.
Among the 11955 aligned Ensembl identiﬁers that passed quality con-
trol, 549 and 158 were respectively signiﬁcantly (FDR<0.05) down
(mean FC<0.667) and up (mean FC>1.5) regulated in lesioned compared
to paired preserved cartilage. Among the total 707 genes that were
differentially expressed, 31 were subject to AI marked by 71 SNPs. As
proof of principle, we here present AI of the COMP gene, detected,
among others, in heterozygous carriers of rs4808155 (ﬁgure 1) which is
in full linkage disequilibrium (D’¼1) with rs8104411, a previously
reported OA susceptibility SNP (Ramos et al. 2014). Furthermore, COMP
was signiﬁcantly up regulated in lesioned cartilage (FDR<0.005,
FC>1.5).
Conclusions: By conﬁrming earlier reports and identifying new genes
likely involved in OA disease progression, we here demonstrate the
power of next generation RNA sequencing. In this respect, the 71
observed genetic variants that confer AI in the 31 genes that addition-
ally mark the OA disease process by differential gene expression, are
likely to be causally or protectively involved in the complex OA path-
ophysiology of articular cartilage, as they stress or attenuate the
observed differential expression of the respective genes. Although these
genetic variants do bear transcriptomic functionality in disease relevant
tissue, additional functional approaches in cell or animal models are
necessary to further characterize such causal relationships.
296
DEMETHYLATION OF AN NUCLEAR FACTOR-KB (NF-KB) ENHANCER
ELEMENT ORCHESTRATES INOS INDUCTION IN OSTEOARTHRITIS
VIA CELL CYCLE REGULATION
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Med., Sendai, Japan
Purpose: Osteoarthritis (OA) is a complex disease of the joint, charac-
terized by progressive degradation of the cartilage matrix by aggreca-
nases and collagenases. In normal adult cartilage, chondrocytes present,
in the non-stressed steady state, as quiescent cells demonstrating
negligible turnover of the cartilage matrix. In contrast, in OA, the
chondrocytes become “activated”, characterized by cell proliferation,
cluster formation, and the increased production of matrix proteins and
matrix-degrading enzymes. Nitric oxide, the product of inducible nitric
oxide synthase (iNOS), not only suppresses the synthesis of cartilage
matrix, but also increases expression of proteases in OA and we have
recently described that demethylation of the NF-kB enhancer region at
5.8 kb of the iNOS gene leads to increased transcription through
elevated binding of this transcription factor. The current study has
examined the methylation proﬁle of the NF-kB enhancer region at 5.8
kb of iNOS and the subsequent role in the induction of OA via cell cycle
regulation.
Methods: Human articular cartilage samples were obtained from 12
patients following hemiarthroplasty as a consequence of femoral neck
fracture (NOF) and from 16 OA patients who underwent total hip
arthroplasty. Isolated primary human chondrocyte samples (n ¼ 7)were cultured for 5 weeks in 2 groups: (i) cultured without treatment
(control culture) and (ii) cultured using 2 mM 5-azadeoxycytidine (5-
aza-dC). Percentage methylation was determined by pyrosequencing,
gene expression by qPCR and cell proliferation was determined using
the MTT assay. Transient transfections using the chondrocytic cell line
C28/I2 were induced to determine the effect of the NF-kB enhancer
region on cell proliferation and the inﬂuence of DNA methylation. Cell
cycle distribution was analysed by ﬂuorescence-activated sorting
(FACS).
Results: Analysis of several NF-kB enhancer elements localised
upstream of the 5.8 kb of the iNOS gene showed that this element is
crucial for induction of the human iNOS promoter in articular chon-
drocytes. In vitro de-methylation with 5-aza-dC showed decreased
levels of DNA methylation at CpG sites localised at 5.8 kb in articular
chondrocytes, which correlated with higher levels of iNOS expression.
In vitro methylation of the NF-kB enhancer region at 5.8 kb increased
the percentage of cells at G0/G1 cell cycle phase. Loss of methylation
within this region correlated with, enhanced proliferation and
increased number of cells at G2/M phase. OA chondrocytes demon-
strated upregulation of the G0/G1 cell cycle progression markers Cyclin
D1 and CDK6 in contrast to control cells.
Conclusions: We demonstrate the loss of methylation that occurs at
speciﬁc CpG sites localised at the 5.8 kb NF-kB enhancer region of the
iNOS gene in OA chondrocytes permits the binding of this transcription
factor activating the expression iNOS. This results in subsequent altered
cell cycle regulation of OA chondrocytes and altered proliferative phe-
notype and transmission of the pathogenic phenotype to daughter cells.
This study indicates that inhibition of cell cycle progression by iNOS
enhancer hypermethylation is capable of reducing pro-inﬂammatory
responses via down-regulation of NF-kB with important therapeutic
implications in OA.
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Purpose: Involvement of inﬂammation in the development and pro-
gression of OA has been implicated. Interleukin 8 (IL-8) is an inﬂam-
matory chemokine, involved in the inﬂammatory process and the
pathophysiology of OA. Importantly, within IL8, the 1000-bp of the
proximal promoter region contains only three CpG sites all located close
to transcriptional binding sites for NF-kB, AP-1 and C/EBP. However, the
methylation status of these CpG sites and subsequent involvement in
the regulation of IL8 regulation remains, to date, unknown. The current
study has examined whether the increased expression of IL8 in human
OA is a consequence of epigenetic regulation, speciﬁcally DNA
hypomethylation.
Methods: Human articular cartilage samples were obtained from 15
patients following hemiarthroplasty as a consequence of femoral neck
fracture (NOF) and from 15 OA patients who underwent total hip
arthroplasty. IL8 expression levels and the percentage CpG methylation
were quantiﬁed by qRT-PCR and pyrosequencing to compare OA
patients with non-OA controls. Isolated primary human chondrocyte
samples (n ¼ 7) were cultured for 5 weeks in 2 groups: (i) cultured
without treatment (control culture) and (ii) cultured using 2 mM 5-
azadeoxycytidine (5-aza-dC). The effect of CpG methylation on IL8
promoter activity was determined using a CpG-free vector; co-trans-
fections with expression vectors encoding NF-kB, AP-1 and C/EBP were
subsequently undertaken to analyse for IL8 promoter activity in
response to changes in methylation status. Furthermore, to determine
the CpG sites critical for IL8 promoter activity, we compared IL8 wild
type promoter construct activity against 6 vectors containing mutations
at different CpG sites.
Results: IL8 expression in OA patients was 37-fold higher than in NOF
patients. OA chondrocytes displayed a 22%, 26% and 15% statistically
signiﬁcant (P<0.01) reduction in methylation status at the -116, -106
and -31 CpG sites respectively. Multiple regression analysis revealed
that the degree of methylation of the CpG site located at 116-bp was
the strongest predictor of IL8 expression. In addition, advanced age and
OA were associated with higher IL8 expression. IL8 expression by
chondrocytes cultured using 5-aza-dC was observed to be 4.0-fold
higher than in control culture chondrocytes. Signiﬁcantly, the
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culture was lower than that in control culture. In vitro DNAmethylation
was noted to decrease IL8 promoter basal activity. Furthermore, NF-kB,
AP-1 and C/EBP strongly enhanced IL8 promoter activity whilst DNA
methylation inhibited the effects of these three transcription factors.
Finally, point mutations created on any single CpG site or two CpG sites
resulted in a signiﬁcant increase in IL8 promoter activity by 3.4 to 5.4
fold.
Conclusions: The current study demonstrates that the increased
expression of IL8 in human osteoarthritic chondrocytes is regulated by
DNA demethylation in cooperation with transcription factors. We show
for the ﬁrst time that the percentage methylation of speciﬁc CpG sites
correlates with IL8 gene expression level in clinical OA samples. Fur-
thermore, DNA methylation of speciﬁc CpG sites appears to be a basal
repressionmechanism of IL8 expression. These ﬁndings offer a potential
predictive marker and a putative target, in this inﬂammatory chemo-
kine, for pharmacological intervention in the treatment of OA and,
potentially, other arthritic diseases.
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Purpose: Runt-related transcription factor 2 (RUNX2) also known as
core-binding factor subunit alpha-1 belongs to the family of runt
domain transcription factors. RUNX2 is essential for the maturation of
osteoblasts and both intramembranous and endochondral ossiﬁcation.
In the articular cartilage, RUNX2 regulates MMP13 expression and is
involved in the pathophysiology of osteoarthritis (OA). However, tran-
scriptional regulation mechanism of RUNX2 in articular chondrocytes is
far from clear. RUNX2 has two major isoforms. Type II isoform is
restricted to osseous cells and mature chondrocytes, and the tran-
scription is initiated at the distal promoter P1. Importantly the RUNX2
P1 promoter has a fragment containing a 600bp of sequence upstream
of the transcription start sufﬁcient for promoter activity, with only a few
CpG sites contained in this region. We hypothesized that methylation
status at speciﬁc CpG sites in the RUNX2 P1 promoter predominantly
regulate promoter activity and correlate with messenger RNA levels in
human chondrocytes.
Methods: The superﬁcial and deep zone of cartilage from patients with
a fracture of the neck of femur (NOF; n ¼ 11) were used for isolation of
non-OA/healthy chondrocytes, whereas cartilage pieces adjacent to
weight-bearing areas of OA femoral heads (lacking surface zones) were
harvested to obtain OA chondrocytes (n ¼ 15). Gene expression levels
and percentage methylation of CpG sites within the RUNX2 P1 pro-
moter were quantiﬁed by qRT-PCR and bisulﬁte pyrosequencing. Iso-
lated primary human chondrocyte samples (n ¼ 6) were cultured for 5
weeks in 3 groups: (i) cultured without treatment (control culture) and
(ii) cultured using 2 mM 5-azadeoxycytidine (5-aza-dC). The effect of
CpG methylation on RUNX2 promoter activity was determined using a
CpG-free vector. Furthermore, to determine the CpG sites critical for
RUNX2 promoter activity, RUNX2 wild type promoter construct activity
was compared against 4 vectors containing mutations at different CpG
sites.
Results: RUNX2 expression in OA and NOF deep chondrocytes were 34-
fold (p < 0.01) and 79-fold (p < 0.01) higher compared to NOF super-
ﬁcial chondrocytes. OA chondrocytes displayed a 10%, 14%, 32% and 41%
statistically signiﬁcant (P<0.01) reduction in methylation status at the
720, 686, 336 and þ17 CpG sites respectively, whereas NOF deep
chondrocytes a 13% and 19% reduction at the -336 and þ17 CpG sites. A
signiﬁcant negative correlation was observed between RUNX2 gene
expression and the percentage methylation of the CpG sites in OA
chondrocytes. MMP13 expression in OA chondrocytes was 27-fold and
89-fold higher than observed n NOF superﬁcial and deep chondrocytes,
respectively. A signiﬁcant positive correlation was observed between
RUNX2 and MMP13 gene expressions in OA chondrocytes. RUNX2
expression by chondrocytes cultured using 5-aza-dCwas observed to be
3.3-fold higher than in control culture chondrocytes. Signiﬁcantly, the
percentage methylation of the CpG site located at 336-bp in 5-aza-dC
culture was lower than observed in control culture (55% vs. 87%). In
vitro DNA methylationwas noted to decrease RUNX2 promoter activity.Point mutations (CG to TG) created at the 336 and þ17 CpG sites
resulted in a signiﬁcant reduction in RUNX2 P1 promoter activity.
Conclusions: The current studies show that the increased expression of
MMP13 in human osteoarthritic chondrocytes is correlated with RUNX2
expression. Critically, we show, methylation status of speciﬁc CpG sites
in the P1 promoter is a key regulator of RUNX2 expression in human
chondrocytes. These studies show for the ﬁrst time that the percentage
methylation of speciﬁc CpG sites correlates with RUNX2 gene expres-
sion level in clinical OA samples. Furthermore, point mutations created
at the 336 and þ17 CpG sites resulted in a signiﬁcant reduction in
RUNX2 P1 promoter activity. These ﬁndings indicate that CpG sites
located at 336 and þ17 are crucial regulators of RUNX2 transcription
and offer a putative target for pharmacological intervention in the
treatment of OA.
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REPLICATE OAI RESULTS
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Purpose: Signiﬁcant inﬂuence of the mtDNA haplogroups on radio-
graphic progression of knee OA (KOA) has been reported. For the
present study, we investigated the inﬂuence of the mtDNA hap-
logroups on radiographic KOA progression in subjects of the CHECK
(Cohort Hip and Cohort Knee) cohort, a running 10-year prospective
multi-center cohort of subjects, with pain and/or stiffness of one and/
or both knees
Methods: We assigned the mtDNA haplogroups to the entire CHECK
cohort (n¼1002 subjects). For this work, according to the criteria
reported elsewhere (van Spil et al. Osteoarthritis Cartilage
2012;20:1278-85), we have selected subjects that did show radio-
graphic KOA at baseline (K&L grade¼1 for the left and/or right knee
since maximum baseline K&L grade¼1, in accordance with the early-
stage OA in CHECK subjects), reaching a total of n¼417 subjects. Pro-
gression in these subjects was deﬁned as an increase of 1 K&L grade
for the left and/or right knee during 5 years follow-up period.
Appropriate statistical analyses, including chi-square contingency
tables, logistic regression models adjusting by gender, age, body mass
index (BMI), bilateral KOA and total WOMAC at baseline, as well as
Receiver Operating Curve (ROC) with their respective Area Under the
Curve (AUC), were carried out using SPSS software (v.19)
Results: The 417 subjects that met the eligibility criteria to study
radiographic progression included 81.1% females and 18.9%males, they
were older than 45 years (mean age: 56.24±5.07 years; range: 45-66)
and had a mean BMI of 26.80 Kg/m2 (range: 15.43-48.85). Chi-square
analysis revealed that the mtDNA haplogroup T signiﬁcantly asso-
ciated with lower risk of radiographic progression (OR¼0.467;
CI¼0.250-0.874; p¼0.015); analysing by mtDNA clusters, the cluster TJ
signiﬁcantly associated with lower risk of progression too (OR¼0.586;
CI¼0.366-0.939; p¼0.025). By comparing each of the mtDNA hap-
logroups with the most common haplogroup H in the regression
model, we detected that carriers of the mtDNA haplogroup T were at
lower risk for K&L grade progression (31.4% progressors) than carriers
of the most common mtDNA haplogroup H (50.6% progressors)
(OR¼0.414; CI¼0.204-0.844; p¼0.015); in terms of mtDNA clusters,
subjects in cluster TJ were at lower risk of progression than subjects in
the cluster HV (OR¼0.551; CI¼0.317-0.955; p¼0.034). Additionally,
either including mtDNA haplogroups or mtDNA clusters in the
regression model, both BMI (OR¼1.064; CI¼1.010-1.120; p¼0.020) and
bilateral KL¼1 at baseline (OR¼3.595; CI¼2.345-5.510; p<0.001) were
also signiﬁcantly associated with an increased risk of radiographic
progression of KOA attending to K&L grade. The AUC of this regression
model was 0.723 and 0.722 after including either haplogroups or
clusters respectively.
Conclusions: This work strengthens the hypothesis that mitochondrial
genome is a key factor in the progression of the KOA disease. As noted in
KOA patients of the OAI cohort, the early identiﬁcation and classiﬁcation
of patients with haplogroup T and the most common haplogroup H
would permit to identify those patients more prone to a rapid radio-
graphic progression of the disease.
